{"id":"https://openalex.org/W4386538569","doi":"https://doi.org/10.1093/neuonc/noad137.280","title":"P11.46.A ACTION: A RANDOMIZED PHASE 3 STUDY OF DORDAVIPRONE (ONC201) IN PATIENTS WITH NEWLY DIAGNOSED H3 K27M-MUTANT DIFFUSE GLIOMA","display_name":"P11.46.A ACTION: A RANDOMIZED PHASE 3 STUDY OF DORDAVIPRONE (ONC201) IN PATIENTS WITH NEWLY DIAGNOSED H3 K27M-MUTANT DIFFUSE GLIOMA","publication_year":2023,"publication_date":"2023-09-01","ids":{"openalex":"https://openalex.org/W4386538569","doi":"https://doi.org/10.1093/neuonc/noad137.280"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/noad137.280","doi":"https://doi.org/10.1093/neuonc/noad137.280","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noad137.280","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/25/Supplement_2/ii84/51443179/noad137.280.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/neuro-oncology/article-pdf/25/Supplement_2/ii84/51443179/noad137.280.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024616176","display_name":"Isabel Arrillaga\u2010Romany","orcid":"https://orcid.org/0000-0001-5951-1225","observed_orcids":["https://orcid.org/0000-0001-5951-1225"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"I Arrillaga-Romany","raw_affiliation_strings":["Massachusetts General Hospital , Boston, MA , United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital , Boston, MA , United States","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057541817","display_name":"Andrew B. Lassman","orcid":"https://orcid.org/0000-0001-7386-9928","observed_orcids":["https://orcid.org/0000-0001-7386-9928"]},"institutions":[{"id":"https://openalex.org/I1340179700","display_name":"NewYork\u2013Presbyterian Hospital","ror":"https://ror.org/03gzbrs57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1340179700"]},{"id":"https://openalex.org/I4390039230","display_name":"Herbert Irving Comprehensive Cancer Center","ror":"https://ror.org/051kc1939","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039230"]},{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A Lassman","raw_affiliation_strings":["Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, New York-Presbyterian Hospital, New York City , NY , United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, New York-Presbyterian Hospital, New York City , NY , United States","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I4390039230","https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017360357","display_name":"Susan Lynne McGovern","orcid":"https://orcid.org/0000-0002-5286-0649","observed_orcids":["https://orcid.org/0000-0002-5286-0649"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S L McGovern","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center , Houston, TX , United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center , Houston, TX , United States","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103236468","display_name":"Sabine Mueller","orcid":"https://orcid.org/0000-0002-8216-9357","observed_orcids":["https://orcid.org/0000-0002-8216-9357","https://orcid.org/0000-0002-3452-5150"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S Mueller","raw_affiliation_strings":["University of California, San Francisco , San Francisco, CA , United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco , San Francisco, CA , United States","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076107697","display_name":"Burt Nabors","orcid":"https://orcid.org/0000-0001-5926-2230","observed_orcids":["https://orcid.org/0000-0001-5926-2230"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L B Nabors","raw_affiliation_strings":["University of Alabama at Birmingham , Birmingham, AL , United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham , Birmingham, AL , United States","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010891460","display_name":"Martin J. van den Bent","orcid":"https://orcid.org/0000-0001-5710-5127","observed_orcids":["https://orcid.org/0000-0001-5710-5127"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]},{"id":"https://openalex.org/I4210149908","display_name":"Erasmus MC Cancer Institute","ror":"https://ror.org/03r4m3349","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M van den Bent","raw_affiliation_strings":["Brain Tumor Center at Erasmus MC Cancer Institute, University Medical Center Rotterdam , Rotterdam , Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brain Tumor Center at Erasmus MC Cancer Institute, University Medical Center Rotterdam , Rotterdam , Netherlands","institution_ids":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110558089","display_name":"Michael A. Vogelbaum","orcid":"https://orcid.org/0000-0002-9833-2374","observed_orcids":["https://orcid.org/0000-0002-9833-2374"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Vogelbaum","raw_affiliation_strings":["Moffitt Cancer Center , Tampa, FL , United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center , Tampa, FL , United States","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028733857","display_name":"Jeff Allen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119210","display_name":"Chimerix (United States)","ror":"https://ror.org/02jsvy381","country_code":"US","type":"company","lineage":["https://openalex.org/I4210119210"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J E Allen","raw_affiliation_strings":["Chimerix, Inc. , Durham, NC , United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chimerix, Inc. , Durham, NC , United States","institution_ids":["https://openalex.org/I4210119210"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088834594","display_name":"Allen S. Melemed","orcid":"https://orcid.org/0000-0002-2553-1575","observed_orcids":["https://orcid.org/0000-0002-2553-1575"]},"institutions":[{"id":"https://openalex.org/I4210119210","display_name":"Chimerix (United States)","ror":"https://ror.org/02jsvy381","country_code":"US","type":"company","lineage":["https://openalex.org/I4210119210"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A S Melemed","raw_affiliation_strings":["Chimerix, Inc. , Durham, NC , United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chimerix, Inc. , Durham, NC , United States","institution_ids":["https://openalex.org/I4210119210"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045679809","display_name":"Rohinton S. Tarapore","orcid":"https://orcid.org/0000-0002-8070-5646","observed_orcids":["https://orcid.org/0000-0002-8070-5646"]},"institutions":[{"id":"https://openalex.org/I4210119210","display_name":"Chimerix (United States)","ror":"https://ror.org/02jsvy381","country_code":"US","type":"company","lineage":["https://openalex.org/I4210119210"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R Tarapore","raw_affiliation_strings":["Chimerix, Inc. , Durham, NC , United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chimerix, Inc. , Durham, NC , United States","institution_ids":["https://openalex.org/I4210119210"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021656597","display_name":"Patrick Yung Wen","orcid":"https://orcid.org/0000-0002-0774-7700","observed_orcids":["https://orcid.org/0000-0002-0774-7700","https://orcid.org/0000-0003-3224-3042","https://orcid.org/0000-0002-2452-0540"]},"institutions":[{"id":"https://openalex.org/I4210102457","display_name":"Center for Neuro-Oncology","ror":"https://ror.org/00z2tp793","country_code":"US","type":"facility","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210102457","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P Y Wen","raw_affiliation_strings":["Center For Neuro-Oncology, Dana-Farber Cancer Institute , Boston, MA , United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center For Neuro-Oncology, Dana-Farber Cancer Institute , Boston, MA , United States","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112042260","display_name":"Timothy Cloughsey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T Cloughsey","raw_affiliation_strings":["University of California Los Angeles , Los Angeles, CA , United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California Los Angeles , Los Angeles, CA , United States","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":14,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4612,"currency":"USD","value_usd":4612},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"Supplement_2","first_page":"ii84","last_page":"ii84"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/onc201","display_name":"ONC201","score":0.9810000061988831},{"id":"https://openalex.org/keywords/imipridone","display_name":"imipridone","score":0.8379999995231628},{"id":"https://openalex.org/keywords/newly-diagnosed-glioma","display_name":"newly diagnosed glioma","score":0.6570000052452087},{"id":"https://openalex.org/keywords/oral-targeted-therapy","display_name":"oral targeted therapy","score":0.6570000052452087},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8709999918937683},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9240000247955322},{"id":"https://openalex.org/keywords/pediatric-brain-tumors","display_name":"pediatric brain tumors","score":0.5849999785423279}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8142913579940796},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.6859291195869446},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.609931468963623},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5744073390960693},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5280110239982605},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5070772171020508},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.4867696762084961},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.4230429530143738},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4122389853000641},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.37316393852233887},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.2601296603679657},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.22787347435951233},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.07417908310890198},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/neuonc/noad137.280","doi":"https://doi.org/10.1093/neuonc/noad137.280","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noad137.280","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/25/Supplement_2/ii84/51443179/noad137.280.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10489515","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10489515","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10489515/pdf/noad137.280.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/neuonc/noad137.280","doi":"https://doi.org/10.1093/neuonc/noad137.280","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noad137.280","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/25/Supplement_2/ii84/51443179/noad137.280.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4386538569.pdf","grobid_xml":"https://content.openalex.org/works/W4386538569.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4385578318","https://openalex.org/W4417357706","https://openalex.org/W4365517017","https://openalex.org/W4392490221","https://openalex.org/W4308977950","https://openalex.org/W4410803081","https://openalex.org/W4416140369","https://openalex.org/W4392089921","https://openalex.org/W4391694006","https://openalex.org/W7172291531"],"abstract_inverted_index":{"Abstract":[0],"BACKGROUND":[1],"H3":[2,101,126,209],"K27M-mutant":[3,102,127,210],"diffuse":[4,128,211,246],"midline":[5],"glioma":[6,177],"is":[7,28,36,46,109,260],"a":[8,43,110,213,242],"universally":[9],"fatal":[10],"malignancy":[11],"primarily":[12],"affecting":[13],"children":[14],"and":[15,31,61,160,199,218],"young":[16],"adults.":[17],"While":[18],"radiotherapy":[19,136],"(RT)":[20],"provides":[21],"transient":[22],"benefit,":[23,193],"no":[24],"effective":[25],"systemic":[26],"therapy":[27],"currently":[29,261],"available":[30],"current":[32],"standard":[33,134],"of":[34,56,63,72,119,187,195,238],"care":[35],"RT":[37],"followed":[38],"by":[39,171,178],"monitoring.":[40],"Dordaviprone":[41],"(ONC201),":[42],"first-in-class":[44],"imipridone,":[45],"an":[47],"oral,":[48],"blood-brain":[49],"barrier":[50],"penetrating,":[51],"selective":[52],"small":[53],"molecule":[54],"antagonist":[55],"dopamine":[57],"receptor":[58],"D2/3":[59],"(DRD2)":[60],"agonist":[62],"the":[64,91,264],"mitochondrial":[65],"protease":[66],"ClpP.":[67],"An":[68],"integrated":[69],"pooled":[70],"analysis":[71],"five":[73],"open-label":[74],"trials":[75],"previously":[76],"demonstrated":[77],"efficacy":[78,154,190],"in":[79,98,121,164,174,263,274],"dordaviprone-treated":[80],"patients":[81,99,122,204,231],"with":[82,100,123,241,267],"recurrent":[83],"disease.":[84,103],"This":[85],"phase":[86],"3":[87,117],"trial":[88],"will":[89,137,168,205,223],"be":[90,138,169,225,233,271],"first":[92],"randomized,":[93,111],"controlled":[94],"study":[95,118],"evaluating":[96],"ONC201":[97,120],"MATERIAL":[104],"AND":[105],"METHODS":[106],"ACTION":[107,259],"(NCT05580562)":[108],"double-blind,":[112],"placebo-controlled,":[113],"parallel-group,":[114],"international":[115],"Phase":[116],"newly":[124],"diagnosed":[125],"glioma.":[129],"Patients":[130,240],"who":[131],"have":[132,206],"completed":[133,219],"frontline":[135],"randomized":[139],"1:1:1":[140],"to":[141,270],"receive":[142],"placebo,":[143],"once-weekly":[144],"dordaviprone,":[145],"or":[146,252],"twice-weekly":[147],"dordaviprone":[148],"on":[149,228],"two":[150],"consecutive":[151],"days.":[152],"Primary":[153],"endpoints":[155],"are":[156,256],"overall":[157],"survival":[158,162],"(OS)":[159],"progression-free":[161],"(PFS)":[163],"all":[165],"participants;":[166],"PFS":[167],"assessed":[170],"response":[172],"assessment":[173],"neuro-oncology-high":[175],"grade":[176],"blind":[179],"independent":[180],"central":[181],"review.":[182],"Other":[183],"objectives":[184],"include":[185],"assessments":[186],"safety,":[188],"additional":[189,268],"endpoints,":[191],"clinical":[192],"quality":[194],"life,":[196],"pharmacokinetics,":[197],"biomarkers,":[198],"healthcare":[200],"resource":[201],"utilization.":[202],"Eligible":[203],"histologically":[207],"confirmed":[208],"glioma,":[212,249],"Karnofsky/Lansky":[214],"performance":[215],"status":[216],"\u226570,":[217],"first-line":[220],"radiotherapy.":[221],"Eligibility":[222],"not":[224,257],"restricted":[226],"based":[227],"age;":[229],"however,":[230],"must":[232],"\u226510":[234],"kg":[235],"at":[236],"time":[237],"randomization.":[239],"primary":[243],"spinal":[244],"tumor,":[245],"intrinsic":[247],"pontine":[248],"leptomeningeal":[250],"disease,":[251],"cerebrospinal":[253],"fluid":[254],"dissemination":[255],"eligible.":[258],"enrolling":[262],"United":[265],"States,":[266],"sites":[269],"open":[272],"internationally":[273],"2023.":[275]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-09-09T00:00:00"}